Potential efficacy of T and B lymphocyte-targeted therapies on articular involvement of patients with rheumatoid arthritis and systemic sclerosis overlap syndrome. Results from a 2-centre series of 19 cases.
Nans LebelIsabelle MarieJulien GrosjeanPauline BrevetMathilde LeclercqAnaël DumontHervé LevesqueYgal BenhamouChristian MarcelliThierry LequerreOlivier VittecoqPublished in: Clinical and experimental rheumatology (2024)
In patients with RA/SSc overlap syndrome refractory to conventional synthetic-DMARDs, T and B lymphocyte-targeted therapies seem to be a promising therapeutic option to control joint activity.